|
CN105821047A
|
|
Isolated nucleic acid coding POPDC1 mutant and application thereof
|
|
CN105821117A
|
|
Standard product for polyploid chromosome detection and preparation method thereof
|
|
CN105779462A
|
|
Isolated nucleic acid for coding KCNJ6 mutant and application thereof
|
|
CN105779461A
|
|
Separated nucleic acid for coding CLN5 mutant and application thereof
|
|
CN105777888A
|
|
Novel mutations of gene SIGMAR1 and application of novel mutations
|
|
CN105368812A
|
|
Saliva preservation solution, preparation method and uses thereof
|
|
CN103431378A
|
|
Composition comprising water-soluble plukenetia volubilis linneo protein powder and preparation method of composition
|
|
CN103405771A
|
|
Pharmaceutical composition and applications thereof
|
|
CN103275987A
|
|
AQP5 gene mutant and application thereof
|
|
CN103053806A
|
|
A synbiotic feed additive, and a preparation method and applications thereof
|
|
CN103834673A
|
|
EXT1 gene mutant and application thereof
|
|
CN103806111A
|
|
Construction method and application of high-throughout sequencing library
|
|
CN103725670A
|
|
Method for extracting nucleic acid from biological sample
|
|
CN103688696A
|
|
Planting method for root and stem type traditional Chinese medicinal materials
|
|
CN103571854A
|
|
SUCLA2 gene mutant and its application
|
|
CN103525821A
|
|
Method and composition for diagnosing PHNED (pure hair-nail ectodermal dysplasia)
|
|
CN102758026A
|
|
HiSeq sequencing technology-based method for detecting hepatitis B virus type and drug resistance gene
|
|
CN103509801A
|
|
Skeletal muscle chloride ion channel gene mutant and its application
|
|
CN103509802A
|
|
SLC25A13 gene mutant and its application
|
|
CN103509799A
|
|
Primary hypertrophic osteoarthropathy virulence gene
|
